Rifaximin 550mgTablet
Antibiotics

Rifaximin 550mg

Rifaximin

Minimally absorbed rifamycin-class antibiotic that acts locally within the GI lumen by inhibiting bacterial RNA polymerase, achieving high intraluminal antibiotic concentrations while avoiding systemic drug exposure and associated systemic side effects. Its three distinct approved indications — traveller's diarrhoea (200mg), hepatic encephalopathy prevention (550mg), and IBS-D (550mg) — across gastroenterology and hepatology make it uniquely versatile. Sun Pharma and Lupin manufacture 200mg, 400mg, and 550mg tablets exported to gastroenterology markets globally.

Strengths

200mg / 400mg / 550mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Rifaximin 200mg / 400mg / 550mg
Dosage Form
Tablet
Available Strengths
200mg / 400mg / 550mg
Packing
10 tablets/strip
Route of Administration
Oral, with or without food
Dosage
Traveler's diarrhea: 200mg TID for 3 days; Hepatic encephalopathy: 550mg BID; IBS-D: 550mg TID for 14 days
Indications
Traveler's diarrhea (non-invasive E. coli), hepatic encephalopathy recurrence reduction, irritable bowel syndrome with diarrhea
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 20-25°C
Shelf Life
36 months
Side Effects
Nausea, flatulence, headache, abdominal pain, rectal tenesmus, ascites, peripheral edema
Precautions
Not for diarrhea with fever or bloody stool; discontinue if worsening; monitor for C. difficile; may affect INR with warfarin

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Azithromycin 500mgTablet

Azithromycin 500mg

Azithromycin

Azalide subclass macrolide antibiotic that achieves exceptionally high and sustained intracellular tissue concentrations — up to 100-fold higher than plasma levels — enabling short 3-day or 5-day treatment courses for respiratory, skin, and sexually transmitted bacterial infections. Its anti-inflammatory properties beyond direct bacteriostasis provide additional clinical benefit in community-acquired pneumonia. Cipla and Alkem Labs manufacture 250mg and 500mg tablets exported globally as a staple of primary care antibiotic formularies.

250mg / 500mg
Amoxicillin 500mgCapsule

Amoxicillin 500mg

Amoxicillin Trihydrate

Aminopenicillin with extended gram-positive and gram-negative bactericidal activity, offering superior oral bioavailability (~90%) compared to ampicillin and the convenience of twice- or thrice-daily dosing for common community infections of the respiratory tract, urinary tract, skin, and ear. It is also a key component of H. pylori triple-eradication therapy and is a WHO Essential Medicine available in both capsule and dispersible tablet forms. Cipla and GSK manufacture 250mg and 500mg capsules exported to primary care markets globally.

250mg / 500mg
Augmentin 625mgTablet

Augmentin 625mg

Amoxicillin + Clavulanate

Fixed-dose combination of amoxicillin with clavulanic acid, a potent beta-lactamase inhibitor that protects amoxicillin from enzymatic degradation and restores its activity against beta-lactamase-producing strains of Staphylococcus, Haemophilus, Moraxella, and Klebsiella commonly encountered in community and hospital settings. Widely prescribed for sinusitis, otitis media, lower respiratory infections, UTIs, animal bites, and dental abscesses resistant to amoxicillin alone. GSK and Cipla supply 625mg and 1g tablets exported as a primary care antibiotic staple worldwide.

625mg / 1g

Need bulk pricing for Rifaximin 550mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote